Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0215077 CATALYST PROCESS MODIFICATION AND POLYMERIZATION THEREOF
The present invention describes a process for preparation of catalyst component comprising contacting magnesium based precursor along with an internal donor...
2016/0215076 POLYVINYL ALCOHOL AND PURIFICATION METHOD THEREOF
Highly purified polyvinyl alcohol (PVA) which meets the standard of pharmaceutical grade is provided. The PVA has of less than 0.1 wt % of residual methanol,...
2016/0215075 REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES
Described are reagents that generate a chemical species initiating a polymerization of at least one kind of monomer by non-resonant multi-photon excitation of...
2016/0215074 CURABLE COMPOSITION FOR PHOTOIMPRINT AND METHOD OF PRODUCING FILM, OPTICAL COMPONENT, CIRCUIT BOARD, OR...
A curable composition for photoimprint at least includes a polymerizable compound component (A) and a photopolymerization initiator component (B) and satisfies...
2016/0215073 UNIFIED COOLING IN MULTIPLE POLYOLEFIN POLYMERIZATION REACTORS
A system and method for a polyolefin reactor temperature control system having a first reactor temperature control path, a second reactor temperature control...
2016/0215072 HEPARAN SULPHATE
A heparan sulphate that binds vitronectin is disclosed.
2016/0215071 AQUEOUS IRON CARBOHYDRATE COMPLEXES, THEIR PRODUCTION AND MEDICAMENTS CONTAINING THEM
A water soluble iron carbohydrate complex obtainable from an aqueous solution of iron (III) salt and an aqueous solution of the oxidation product of one or...
2016/0215070 MICRO CHIRAL REGULATION CELLULOSE CHROMATOGRAPHY STATIONARY PHASE, PREPARATION METHOD AND USE THEREOF
The present invention discloses a cellulose derivative shown as formula (I), which is obtained as follows: the hydroxyl at position 6 of microcrystalline...
2016/0215069 Reversibly crosslinked cellulose ethers and process for the production thereof by selective oxidation of...
Reversibly crosslinked, water-soluble cellulose ethers having at least two different ether components is disclosed. At least one ether component is an alkyl,...
2016/0215068 CROSS-METATHESIZED POLYSACCHARIDE DERIVATIVES AND PROCESSES FOR PREPARING THEM
Methods for the cross-metathesis of polysaccharides with one or more olefin-terminated side chains and cross-metathesized products are described. In an...
2016/0215067 ANTI-CEP ANTIBODY OR FRAGMENT THEREOF
An isolated anti-carboxyethylpyrrole (anti-CEP) antibody or antigen binding portion thereof includes a heavy chain variable domain that includes three CDRs...
2016/0215066 ANTHROPOGENIC INSECT-RESISTANT GENE AND CRY1C TOXIN IDIOTYPE SINGLE-CHAIN ANTIBODY ENCODED THEREBY AND...
An anthropogenic insect-resistant gene having a nucleotide sequence represented by SEQ ID NO.1, and a Cry1C toxin idiotype single-chain antibody encoded by...
2016/0215065 NSP4 INHIBITORS AND METHODS OF USE
The invention provides NSP4 inhibitors (such as anti-NSP4 antibodies) and methods of using the same.
2016/0215064 Antibodies Specific for Urokinase-Type Plasminogen Activator and Methods of Use Thereof
The present disclosure relates to antibodies specific for urokinase-type plasminogen activator (uPA). According to certain embodiments, the anti-uPA antibody...
2016/0215063 HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
2016/0215062 PREPARATION USEFUL FOR, AND METHOD FOR TREATMENT OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT)
A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which...
2016/0215061 Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO FcGammaRIIB
The present invention is directed to methods and compositions for the production of Fc-containing polypeptides which are useful as human or animal therapeutic...
2016/0215060 CHICKEN ANTIBODY TRANSFORMED INTO CYSTEINE AND SITE-SPECIFIC CONJUGATION USING SAME
A framework fragment derived from a chicken antibody, in which an amino acid at a particular position is replaced by cysteine, a heavy chain variable region or...
2016/0215059 ICOS BINDING PROTEINS
The present invention relates to an ICOS binding protein, or antigen binding portion thereof that is an agonist human ICOS and does not induce complement,...
2016/0215058 SINGLE-CHAIN VARIABLE FRAGMENT ANTI-CD133 ANTIBODIES AND USES THEREOF
Disclosed herein are a monoclonal antibody that specifically binds to human CD133 and single-chain variable fragments thereof. Also disclosed herein is a...
2016/0215057 METHOD FOR TREATING AND/OR PREVENTING ATRIAL FIBRILLATION
Disclosed herein is a method for treating and/or preventing atrial fibrillation in a subject, comprising administering to the subject a pharmaceutical...
2016/0215056 Human Immune Therapies Using a CD27 Agonist Alone or in Combination with Other Immune Modulators
Methods of inducing T cell proliferation and expansion in vivo for treating conditions wherein antigen-specific T cell immune response are therapeutically...
2016/0215055 FasR ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
Provided herein are an exogenous antibody that binds selectively to a misfolded form of human FasR, and methods and uses for said antibody. Specifically...
2016/0215054 TREATMENT OF DIABETES MELLITUS, METHODS AND COMPOSITIONS THEREFOR
Methods of treatment of diabetes are disclosed. These methods include administration of an inhibitor of chemokine XCL1, and administration of an inhibitor of...
2016/0215053 CXCL12 (CHEMOKINE (C-X-C MOTIF) LIGAND 12) AND IGFBP2 INHIBITORS FOR THE APPLICATION IN THE TREATMENT OF...
The subject of the invention is the application of CXCL12 (Chemokine (C-X-C motif) Ligand 12) and IGFBP2 inhibitors for the treatment of diabetes mellitus...
2016/0215052 ANTI-GALECTIN-1 (GAL1) MONOCLONAL ANTIBODIES AND FRAGMENTS THEREOF FOR NEUTRALIZING GAL1
The present invention is based, in part, on the discovery of galectin 1 (Gal1) epitopes against which anti-Gal1 agents can neutralize Gal1 function, as well as...
2016/0215051 PROTEIN FORMULATION
The present invention relates to methods of minimizing the aggregation of BiTE.RTM. molecules in solution. In one embodiment, a method of the invention is used...
2016/0215050 Nucleolin Antibodies
The present invention provides for methods of producing human monoclonal antibodies to human nucleolin, cells producing such antibodies, and the antibodies...
2016/0215049 HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF
The present invention is directed to antibodies and fragments thereof having binding specificity for ACTH. Embodiments of this invention relate to the binding...
2016/0215048 IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES
The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention...
2016/0215047 BISPECIFIC ANTIBODY AGAINST TNF-ALPHA AND SYNOVIAL MICROVASCULATURE OF ARTHRITIS PATIENTS
The present invention provides bispecific molecule comprising: (i) a first antigen binding portion which specifically targets the synovial microvasculature of...
2016/0215046 SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY
The present invention relates to the finding that TL1A enhances differentiation of TH17 cells, and enhance IL17 secretion from TH17 cells. In one embodiment,...
2016/0215045 VEGFA/Ang2 Compounds
The present invention relates to compounds that bind to human vascular endothelial growth factor A (VEGFA) and human angiopoietin-2 (Ang2), and may be useful...
2016/0215044 HIGH CONCENTRATION FORMULATIONS OF ANTI-C5 ANTIBODIES
The present disclosure relates to, inter alia, stable aqueous solutions comprising a high concentration of an antibody that binds to human complement component...
2016/0215043 PRODUCT AND METHOD FOR TREATING SARCOPENIA
A method of treating sarcopenia comprises administering to a subject a composition comprising an anti-AGE antibody. The method may also be used for preventing...
2016/0215042 METHODS FOR MODULATING IMMUNE RESPONSES DURING CHRONIC IMMUNE CONDITIONS BY TARGETING METALLOTHIONEINS
Described herein are novel compositions comprising MT1 and/or MT2 modulators (i.e., inhibitors or activators), and methods using these agents for targeting...
2016/0215041 Methods of Improving the Therapeutic Efficacy and Utility of Antibody Fragments
The present disclosure relates to methods and uses of improving the therapeutic efficacy and utility of antibody fragments by employing anti-epitope-tagging...
2016/0215040 Human Antibodies to Ebola Virus Glycoprotein
The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to Ebola virus glycoproteins, pharmaceutical compositions...
2016/0215039 AGENTS AND METHODS BASED ON THE USE OF THE EDA DOMAIN OF FIBRONECTIN
This invention relates to the use of a polypeptide in the production of an immunostimulatory agent, said polypeptide comprising a sequence corresponding to the...
2016/0215038 SOLUBLE CD33 FOR TREATING MYELODYSPLASTIC SYNDROMES (MDS)
Disclosed are compositions and methods for treating disease or condition caused or exacerbated by S100A9 activity, such as myelodysplastic syndromes (MDS)...
2016/0215037 NOVEL DERIVATIVE OF AN INSULIN ANALOGUE
The present invention provides a novel derivative of an analogue of human insulin, useful for the treatment of diabetes.
2016/0215036 STABILIZED POLYPEPTIDE INSULIN RECEPTOR MODULATORS
Provided herein are stabilized .alpha.-CT polypeptides comprising an alpha-helical segment, and wherein the polypeptide is of Formula (I-1) or Formula (I-2): ...
2016/0215035 INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF
The present invention relates to interleukin-4 receptor binding fusion proteins. More specifically, the invention provides, in part, fusion proteins that...
2016/0215034 WATER-SOLUBLE EXPRESSION AND PURIFICATION METHOD OF HUMAN GCSF RECOMBINANT PROTEIN HAVING BIOLOGICAL ACTIVITIES
The present invention relates to a water-soluble expression and a purification method of a human granulocyte colony-stimulating factor (hGCSF) recombinant...
2016/0215033 Granulocyte Macrophage Colony-Stimulating Factor Compositions
The present invention provides a composition of homogeneously glycosylated GM-CSF or a homogeneously glycosylated fragment thereof, wherein each molecule of...
2016/0215032 Influenza Nucleoprotein Vaccines
The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp...
2016/0215031 METHOD OF TREATING DISORDERS REQUIRING DESTRUCTION OR REMOVAL OF CELLS
The embodiments include methods of treating conditions requiring removal or destruction of cellular elements, such as benign or malignant tumors in treatment...
2016/0215030 Dialysis-Free Process for Aqueous Regenerated Silk Fibroin Solution and Products Thereof
The present invention provides a dialysis-free process for the generation of aqueous regenerated silk fibroin solutions. A degumming reactor is presented that...
2016/0215029 Polypeptides Comprising an Ice-Binding Activity
The present invention relates to novel polypeptides comprising an ice-binding capability resulting in an ice crystal formation and/or growth reducing or...
2016/0215028 BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS (MAP)
Described are methods and products useful for identifying subjects with Mycobacterium avium subspecies paratuberculosis (MAP). A number of protein antigens...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.